Clinical outcome after 36 months of treatment with injections of autologous blood for recurrent dislocation of the temporomandibular joint

Publication date: January 2018
Source:British Journal of Oral and Maxillofacial Surgery, Volume 56, Issue 1
Author(s): H. Yoshida, Y.-i. Nakatani, S. Gamoh, K. Shimizutani, S. Morita
We investigated the prognosis after three years of treatment for recurrent dislocation of the temporomandibular joint with autologous blood given intravenously in 21 patients with a mean (range) age 64 (17-92) years of whom 16 had coexisting systemic disease. The mean (range) follow up from the first injection was 64 (41-99) months. Eighteen patients had no recurrence during the first 36 months after their first injection, which showed that this minimally-invasive treatment was effective, particularly for those who had conditions that made a mouthpiece or operation unsuitable.



http://ift.tt/2ALnIGA